A Phase II Multicenter Study of Enfortumab Vedotin with or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE).Elias Chandran,Nicholas I. Simon,Daniel Da Motta Girardi,Lisa Ley,Tzu-Fang Wang,Andre Rashad Kydd,Saad Omar Atiq,Salah Boudjadi,Ian Stukes, Elizabeth Smith,Dilara Akbulut,Scot Anthony Niglio,Sandeep Gurram,Marijo Bilusic,Seth M. Steinberg,Andrea B. ApoloJournal of Clinical Oncology(2024)引用 0|浏览9AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要